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Abstract
A computational methodology based on Metropolis Monte Carlo (MC) and the weighted histogram analysis
method (WHAM) has been developed to calculate the absolute binding free energy between functionalized
nanocarriers (NC) and endothelial cell (EC) surfaces. The calculated NC binding free energy landscapes yield
binding affinities that agree quantitatively when directly compared against analogous measurements of specific
antibodycoated NCs (100 nm in diameter) to intracellular adhesion molecule- 1 (ICAM-1) expressing EC
surface in in vitro cell-culture experiments. The effect of antibody surface coverage (σs) of NC on binding
simulations reveals a threshold σs value below which the NC binding affinities reduce drastically and drop
lower than that of single anti-ICAM-1 molecule to ICAM-1. The model suggests that the dominant effect of
changing σs around the threshold is through a change in multivalent interactions; however, the loss in
translational and rotational entropies are also important. Consideration of shear flow and glycocalyx does not
alter the computed threshold of antibody surface coverage. The computed trend describing the effect of σs on
NC binding agrees remarkably well with experimental results of in vivo targeting of the anti- ICAM-1 coated
NCs to pulmonary endothelium in mice. Model results are further validated through close agreement between
computed NC rupture-force distribution and measured values in atomic force microscopy (AFM)
experiments. The three-way quantitative agreement with AFM, in vitro (cell-culture), and in vivo experiments
establishes the mechanical, thermodynamic, and physiological consistency of our model. Hence, our
computational protocol represents a quantitative and predictive approach for model-driven design and
optimization of functionalized nanocarriers in targeted vascular drug delivery
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A computational methodology based on Metropolis Monte Carlo
(MC) and the weighted histogram analysis method (WHAM) has
been developed to calculate the absolute binding free energy
between functionalized nanocarriers (NC) and endothelial cell
(EC) surfaces. The calculated NC binding free energy landscapes
yield binding affinities that agree quantitatively when directly
compared against analogous measurements of specific antibody-
coated NCs (100 nm in diameter) to intracellular adhesion mole-
cule-1 (ICAM-1) expressing EC surface in in vitro cell-culture experi-
ments. The effect of antibody surface coverage (σs) of NC on
binding simulations reveals a threshold σs value below which
the NC binding affinities reduce drastically and drop lower than
that of single anti-ICAM-1 molecule to ICAM-1. The model suggests
that the dominant effect of changing σs around the threshold
is through a change in multivalent interactions; however, the
loss in translational and rotational entropies are also important.
Consideration of shear flow and glycocalyx does not alter the
computed threshold of antibody surface coverage. The computed
trend describing the effect of σs on NC binding agrees remarkably
well with experimental results of in vivo targeting of the anti-
ICAM-1 coated NCs to pulmonary endothelium in mice. Model
results are further validated through close agreement between
computed NC rupture-force distribution and measured values in
atomic force microscopy (AFM) experiments. The three-way quan-
titative agreement with AFM, in vitro (cell-culture), and in vivo
experiments establishes the mechanical, thermodynamic, and
physiological consistency of our model. Hence, our computational
protocol represents a quantitative and predictive approach for
model-driven design and optimization of functionalized nanocar-
riers in targeted vascular drug delivery.
absolute binding free energy ∣ Monte Carlo ∣ targeted drug delivery ∣
multivalent interactions ∣ antibody surface coverage
Targeted delivery of functionalized nanocarriers (i.e., NCscoated with specific targeting ligands) to endothelium re-
mains an important design challenge in pharmacological and
biomedical sciences. The use of functionalized NCs offers a wide
range of targeting options through tunable design parameters
(size, shape, type, method of functionalization, etc.). This neces-
sitates a multiparameter optimization for achieving efficacious
targeting in drug delivery applications (1) including vascular-tar-
geting in oncology (2–4).
Rational design of functionalized NCs faces many challenges
owing to the complexities of molecular and geometric parameters
surrounding receptor–ligand interactions and NCs (5–9), lack of
accurate characterization of hydrodynamic, physico-chemical
barriers for NC uptake/arrest (10–14), and uncertainty in target-
ing environment in vivo (15–17).
Among the factors impacting the design of NCs and therapeu-
tic agents are: (i) binding affinity (18); (ii) multivalency or
the average number of receptor–ligand bonds per bound NC
(19–23); and (iii) in vivo targeting, measured as percentage of
injected dose accumulated after intravenous injection (18).
Recently the binding affinity of functionalized NCs to ICAM-1
expressing EC surface has been studied experimentally. Muro et
al. (18) reported that the binding association constant (Ka) of
anti-ICAM-1 coated NC to EC can be two orders of magnitude
higher than that of anti-ICAM-1 binding to ICAM-1. Haun and
Hammer (24) investigated the kinetic rate constants of attach-
ment and detachment of 210 nm NCs as a function of receptor
density, ligand density on surface, and flow shear rate and
identified a time dependence of the detachment rate due to
multivalent binding. Ho et al. (25) studied the effect of antibody
surface coverage (σs) on equilibrium binding constants bymeasur-
ing fractional coverage of bound NCs (80 nm in diameter) as
a function of NC concentrations; by fitting their experimental
data, they observed linear dependence of Ka on σs, leading them
to conclude that the system was dominated by monovalent
interactions. Despite such previous studies on NC binding, a com-
prehensive understanding of the determinants of NC binding
to EC in vitro and in vivo is lacking; this hampers rational design.
Computational determination of the binding affinities is a sig-
nificant challenge because it involves the calculation of absolute
binding free energies. This requires extensive sampling over con-
formational space and determination of various (translational
and rotational) entropy changes upon binding. Using atomistic
models, Woo and Roux (26) developed a general methodology
to calculate Ka between a flexible ligand and a receptor based
on the potential of mean force (PMF). Following the framework
in ref. 26, here we develop a model to calculate the binding affi-
nity of spherical NC functionalized with anti-ICAM-1 antibody to
ICAM-1 expressing EC surface. Using a Monte Carlo approach,
we compute the PMF profiles between NC and the EC surface
and determine the absolute binding affinities. The important
advantage of this protocol is that it allows us to systematically
investigate the effects of a wide range of experimentally tunable
parameters, including the receptor surface density, antibody
coverage on NC (σs), flexural rigidity of the receptors, presence
of glycocalyx, and effect of shear flow. We show that our model
predictions can quantitatively describe the results of three broad
classes of experiments, namely: (i) binding measurements of NCs
in cell culture, (ii) in vivo targeting of NC to lung EC in mice, and
(iii) biophysical characterization of NC–EC interaction using
atomic force microscopy (AFM). For all cases investigated,
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model predictions agree remarkably well with experimental
observations. Our results, thus, provide quantitative mechanistic
understanding as well as help establish guiding principles for
rational design of NC for efficacious EC targeting under various
in vitro (cell-culture) and in vivo conditions.
Model
Model Parameters andMC Simulations.The NC is modeled as a rigid
sphere (100 nm in diameter), and both the ligands and receptors
are modeled as cylinders with reactive tips. The NC is constructed
by uniformly distributing Nab antibodies (anti ICAM-1) onto its
surface (see Fig. 1). To make direct contact with the experimental
system (18), the receptor parameters are chosen to mimic ICAM-
1. The model parameters are summarized in Table S1.
The ligand parameters are chosen to mimic the murine anti-
ICAM-1 antibody, which binds specifically to ICAM-1. The Bell
model (27) provides the interactions between antibody and
ICAM-1 through the reaction free energy: ΔGrðdÞ ¼ ΔG0þ
1
2
kd2, where d represents the distance between the reaction sites
of the interacting antibody and ICAM-1, ΔG0 is the free energy
change at equilibrium state (d ¼ 0) and k is the interaction bond
force constant. Muro et al. (18) reported the equilibrium free en-
ergy change between antibody and ICAM-1 to be −7.98 × 10−20 J
at 4 °C, which we set as ΔG0 in our simulations. We obtain the
bond spring constant k ¼ 1;000 dyn∕cm by fitting rupture-force
distribution data reported from single-molecule force spectro-
scopy (28, 29). Both ΔG0 and k are assumed to be tempera-
ture-independent based on which we derive the value of the
reactive compliance γ (distance along the reaction coordinate
to reach the transition state or point of rupture) to be
∼0.4 nm, which agrees very well with experimental evaluations
(29, 30). We also account for the ICAM-1 flexure (Fig. 1). Be-
cause the exact flexural rigidity for ICAM-1 proteins is not avail-
able in the literature, we set the flexural rigidity 7;000 pN·nm2,
which lies between glyco-proteins (700 pN·nm2) and the actin
filament (15–73 × 103 pN·nm2) (10). An orientational bias MC
sampling technique (31) is employed to explore the configura-
tions of flexural movement while regular Metropolis Monte
Carlo steps are employed for: (i) bond formation/breaking,
(ii) NC translation and rotation, and (iii) ICAM-1 translation.
Move i is selected randomly with a probability of 50%, and in
the remaining 50%, the NC translation, rotation, and ICAM-1
translation are selected randomly with probability of 0.5 Nab∕
Nt, 0.5 Nab∕Nt, and ðNt −NabÞ∕Nt respectively; Nt is the com-
bined total number of antibodies (Nab) and ICAM-1 molecules.
The simulations are run in parallel on four processors with
different realizations of the same physical system. The error bars
are reported as the standard deviation across multiple (four)
realizations. An adaptive step size for NC translation/rotation
and ICAM-1 diffusion is implemented to ensure a Metropolis
acceptance rate of 50%.
Absolute Binding Free Energy. For binding of ligands (L) (or NC)
to receptors (R), the binding process can be described as:
L þ R ⇌ LR, where LR is the ligand and receptor in binding
state. At thermodynamic equilibrium, the binding affinity (or as-
sociation constant) Ka is defined as:
Ka ¼
½LR
½L½R ¼
p1½Rtot
½Lp0½Rtot
¼ 1½L ×
p1
p0
: [1]
Here ½L, ½R, and ½LR are concentrations of each species. We
define p0 and p1 as the fraction of receptors with no ligand and
one ligand bound respectively, so that ½R and ½LR can be ex-
pressed as ½R ¼ p0½Rtot and ½LR ¼ p1½Rtot, where ½Rtot is the
total receptor concentration in the whole system. We relate
the fraction in Eq. 1 to the ratio of the integral of configurational
degrees of freedoms in the bound state to the unbound state (26):
Ka ¼
1
½L ×
R
bound d1dXe
−βUbound
R
unbound d1dXe
−βUunbound
; [2]
where Ubound and Uunbound are the total potential energies of
the system at bound and unbound states, β ¼ 1∕kBT in which
kB is the Boltzmann constant and T is the absolute temperature.
1 represents all the degrees of freedom associated with the ligand
(NC) and X is the degrees of freedom for the remaining mole-
cules (receptors). On a per ligand basis, the ligand concentration
is ½L ¼ 1∕V unbound, where the denominator is the volume acces-
sible to an unbound ligand. The integral associated with the
unbound state (Uunbound ¼ 0) in Eq. 2 is determined over transla-
tional degrees of freedom (yielding the volume V unbound), and
rotational degrees of freedom (yielding a factor of 8π2 in three
dimensions).
We choose a reaction coordinate z along which we perform
umbrella sampling with harmonic biasing potentials. The umbrel-
la sampling is performed with window size of Δz ¼ 0.05 nm, and
the harmonic biasing potential in each window is chosen to be
0.5kuðz − z0;iÞ2, where 0.5kuðΔzÞ2 ¼ 1.0 × 10−20 J, ku is the
harmonic force constant and z0;i is the location of the center
of window i. The NC is slowly moved to the cell surface by updat-
ing z0;i. A total of 200 million Monte Carlo steps are performed
in each window, and the histogram is stored only when there
exists at least one bond. All the relevant parameters including
the window size Δz, strength of the biasing potential ku, and
the sampling size in each window have been tested to ensure con-
vergence. The weighted histogram analysis method (WHAM)
algorithm (32) is used to unbias and combine the histograms
in different windows to form a complete PMF (W ðzÞ) profile
using a tolerance factor of 10−6. PMF profiles for each system
are averaged over four independent realizations and the standard
deviation is reported as the error bar.
Binding of Antibody-Coated NC to EC Surface. In calculating Ka for
antibody-coated NC using a Langmuir model framework (see
section S2 in SI Text), we first compute the PMF (W ðzÞ) profiles
of NC binding to receptors expressed on a minimal patch on the
EC surface, which allows firm binding; here the reaction coordi-
nate z is defined as the vertical distance between the center of
NC and the EC surface. The binding association constant is
calculated as:
Ka ¼
1
½L × T1 × T2 × T3: [3]
Three terms T1–T3 account for entropy loss upon binding: T1
accounts for the entropy loss of receptors associated with binding
to the minimal patch:
NC
glycocalyx
cell surface
θ
φ
antigen flexure
antigen (ICAM-1)
antibody (anti-ICAM-1)
NC nanocarrier
Fx
Ty
u=S*(z-h)
z=0
H
h=2a
a
z
Fig. 1. Schematic of the NC adhesion model. The adhesion is mediated
through interactions between anti-ICAM-1 antibody on NC (radius a ¼
50 nm) and ICAM-1s on EC surface. The ICAM-1 flexure is taken into account
by allowing it to bend and rotate in θ and ϕ, a steady shear flow with
shear rate of S as well as glycocalyx with height of h ¼ 2a are introduced.
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T1 ¼
Að1ÞR;b × A
ð2Þ
R;b ×… × A
ðNbÞ
R;b
Að1ÞR;ub × A
ð2Þ
R;ub ×… × A
ðNbÞ
R;ub
; [4]
where AðnÞR;b is the accessible surface area of the nth bound recep-
tor in its bound state andAðnÞR;ub is the accessible surface area of the
nth receptor in its unbound state. T2 is associated with the NC
rotational entropy loss in binding, and T3 is related to loss of
NC translational entropy:
T2 ¼
ðNab∕NbÞΔω
8π2
; T3 ¼
ANC;b
R
e−βW ðzÞdz
ANC;ublz
; [5]
where Nb is the total number of bonds in equilibrium state. Δω is
the rotational volume of the NC in the bound state which is
quantified using the rmsd of Euler angles (see section S3 in
SI Text) (33). ANC;b is the accessible area to the NC in the bound
state, ANC;ub and ANC;ublz are the area and volume accessible to
the NC in the unbound state, and W ðzÞ is the calculated PMF
profile. T1–T3 and W ðzÞ are computed from our simulations
(see Results). Substitution of the NC concentration ½L ¼ 1∕
ðANC;ublzÞ in Eq. 3 yields the final expression of the binding
constant Ka.
Results
Binding of NC to EC Surface.We initially set Nab ¼ 162, which cor-
responds to 74% of saturation coverage (see Materials and Meth-
ods). The computed PMF (Fig. 2A) at T ¼ 27 °C indicates three
firm bonds on average (multivalency or Nb ¼ 3) characterized by
a PMF well of 32kBT when projected along z. The PMF change is
smaller for the second and third bonds compared to the first as a
result of ICAM-1 flexure and differences in loss in translational
and rotational entropies of NC as well as ICAM-1. The multiva-
lency or the number of bonds formed at equilibrium is affected by
the bond reaction free energy, bond spring constant, ICAM-1
bending rigidity, antibody surface coverage (Fig. S5), and NC size
(Figs. S3 and S4). Fig. 2B also shows the projection (on the xy
plane) of the spatially averaged distribution of bound ICAM-1
relative to the center of NC. The outer envelope of the bond dis-
tribution in B defines the minimal patch on the EC surface for
compete NC binding; the first bound ICAM-1 can freely access
the area within the outer circle with outer radius ro ¼ 12.5 nm
(see section S2 of SI Text), yielding Að1ÞR;b ¼ πr2o, the second bound
ICAM-1 can only access the area within the annulus between the
outer and inner circles (inner radius ri ¼ 9.7 nm) with corre-
sponding Að2ÞR;b ¼ πðr2o − r2i Þ, and the third bound ICAM-1 is re-
stricted to a patch with accessible area Að3ÞR;b ¼ ðro − riÞ2. In
contrast, each of these ICAM-1 molecules in the unbound state
can access a surface area of πr2o. Similarly, the translational area
accessed by a bound NC is ANC;b ¼ ðro − riÞ2, and as stated above
the rotational mobility of bound NC Δω is estimated from the
rmsd of Euler angle fluctuations in the bound state, (see sec-
tion S3 of SI Text and Fig. S2). Substitution into Eq. 3 yields
the expression:
Ka ¼
ðNab∕3ÞΔω
8π2
×
πðr2o − r2i Þðro − riÞ4
R
e−βW ðzÞdz
ðπr2oÞ2
: [6]
Based on the calculated PMF in Fig. 2, the computed binding
association constant Ka ¼ 5.9 × 1010 nm3 and the dissociation
constant Kd ¼ 1∕Ka ¼ 28.0 pM, which compares very favorably
with the in vitro measurement of 77 pM under similar conditions
at a temperature of 4 °C (18) (see section S2 of SI Text and
Fig. S1).
Effect of Antibody Surface Coverage.The antibody surface coverage
on NC (σs) is a tunable experimental parameter shown to influ-
ence NC binding in vitro (34). To study the effect of σs, we carried
out simulations with antibody surface coverages Nab ¼ 12, 42, 60,
75, 100, 140, and 162 per NC (i.e., σs ∼ 5–74% of saturation cover-
age). The computed PMF profiles and corresponding bond
distributions are provided in section S6 of SI Text and Fig. S5,
and the corresponding binding association constant as a function
of antibody coverage is provided in Fig. 3A.
From Eq. 5, σs impacts the NC binding constant in two ways:
(i) the multiplicity factorNab∕Nb is a geometric effect and defines
a linear dependence of Ka on σs when the multivalency is unal-
tered; (ii) the more significant effect results from changes in the
calculated PMF profiles due to changes in multivalency, which
exponentially affects Ka, (through the exponential integration
term in Eq. 5). In Fig. 3A, the linear dependence is verified
(see dotted lines) for the two ranges of σs, which support constant
multivalency. Below a threshold value of σs ∼ 45%, there is an
exponential decrease in Ka where the PMF drops by∼8kBT as the
average multivalency decreases from three to two. Significantly,
for σs < 45%, the Ka of NC is lower than that of free antibody
binding to ICAM-1 (see dash-dot blue line). The primary reason
for the decrease of Ka for NC below that of free ICAM-1-anti-
body value is that the rotational entropy loss of the NC (Eq. 5) is
much greater than that for the free ICAM-1-antibody binding.
Further discussion on the regime σs ≪ 1 is provided in section S5
of SI Text.
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Fig. 2. (A) Calculated PMF WðzÞ as function of distance between center of
NC and cell surface. (B) The averaged spatial distribution antibody-ICAM-1
bound pairs at equilibrium state indicated by the arrow in A projected on
the EC surface (xy plane). The antibody surface density is σs ¼ 162∕NC, which
corresponds to 74% of saturation coverage. The dotted circle represents the
projection of NC boundary on the EC surface, provided as a reference.
# of Ab/NC
En
do
th
el
ia
lT
a
rg
e
tin
g
(%
)
0 100 200
0
50
100
150
B
# of Ab/NC
K a
(n
m
3 )
0 100 20010
7
108
109
1010
1011
1012
Single Ab-Antigen
A
Fig. 3. The computed binding association constant Ka as a function of anti-
body surface coverage σs (A). The dotted lines represent linear dependence
of σs, the blue dash-dot line indicates the binding affinity of single antibody
to ICAM-1. The error bars are calculated from four independent realizations.
In calculating the PMF of NC at σs ¼ 45%, three out of the four realizations
yielded an average multivalency of three, while the other realization yielded
an average multivalency of two; hence the Ka values are computed and
plotted separately for the two cases. This dependence of multivalency on
the spatial distribution of the antibodies on NC suggests that, owing to
the heterogeneity, the experiments will show a continuous increase in
Ka over a narrow range of σs, rather than a discontinuity at the threshold
σs value. (B) In vivo endothelium targeting of NCs with varying surface
coverage with anti-ICAM-1 molecules in mice. The dotted line is the plot of
IgG coated NC and provides a background for nonspecific ICAM targeting.
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Effect of Hydrodynamic Shear and Glycocalyx.To evaluate the role of
hydrodynamic force, as displayed in Fig. 1, a steady shear flow
with a shear rate S is considered. The force and torque exerted
on the NC (Fx and Ty in Fig. 1) are computed by solving the
Stokes equation. The effect of shear on the specific binding of
NC is investigated by comparing the equilibrium distributions
of multivalency in the presence and absence of shear for a range
of σs values (see section S7 of SI Text and Fig. S6). Even though
the magnitude of the shear force on the 100 nm NC is small (the
energy change of the NC due to the shear gradient is 2% of kBT),
shear flow does quantifiably perturb the distribution of multiva-
lency (Fig. S6) and introduces a slight asymmetry in the distribu-
tion of flexure angles. This effect is small, and the flow-field is not
expected to alter the adhesion landscape nor the computed bind-
ing affinity (which were both computed under zero shear) except
for the low antibody coverage (σs ≤ 14%). In this case, as evident
from the low σs cases in Fig. S6, the population of states with
multivalency less than two under shear is increased, which implies
that a shear induced detachment of the NC is likely.
We account for the glycocalyx by introducing a layer of
h ¼ 100 nm in height above the cell surface. In ref. 10, the flow
in the glycocalyx layer is described using the Brinkman equation.
Here, we only consider the effect of glycocalyx in the absence of
flow by considering the normal resistance through a harmonic
potential 1∕2kglyxH2 per unit differential area of the NC surface
immersed in the glycocalyx; H is the penetration depth of the
NC into glycocalyx (see Fig. 1) and kglyx is the glycocalyx stiffness.
We obtain kglyx by fitting in vivo experimental data (15). This
enables us to compute a difference in free energy of binding
in the presence and absence of glycocalyx: ΔEglyx ¼ 13 kglyxπa4∼
6kBT, when the NC is fully immersed in the glycocalyx (28).
The effect of the glycocalyx layer is to alter (lower) the PMF and
decrease the binding affinity for all values of σs (see Fig. S7).
Presence of the glycocalyx does not alter the effect of antibody
surface coverage on the binding affinity but significantly de-
creases the fractional binding of NC for a given value of σs. Taken
together, the data in Fig. 3 and Figs. S6 and S7 implies that for
100 nm NCs, the trends we have computed from equilibrium
binding data in the absence of flow for characterizing the effect
of σs may apply both to cell-culture experiments in moderate
shear flow (S ≤ 6;000 s−1), in vivo experiments, where the bind-
ing may occur in the presence of glycocalyx.
Comparison with in Vivo Experiments. For a direct comparison of
the predicted Ka vs. σs, we quantified endothelial targeting as
a function of lung uptake of NCs in mice. Lung uptake is repre-
sentative of endothelial targeting because the lung accounts for
roughly 30% of the endothelium in vivo (35). Moreover, addi-
tional data (see Fig. S8 and section S8 of SI Text) indicate that
only uptake in the pulmonary vasculature is dependent on the
number of anti-ICAM molecules; thus we do not account for
nontargeted tissues, because the uptake of particles in the main
reticuloendothelial system (RES) organ, liver, did not change
with variations of the anti-ICAM surface density. Fig. 3B depicts
endothelium targeting of NCs with varying surface coverage with
anti-ICAM-1 molecules. Full coverage of NCs was expressed
as 100% endothelium targeting because it corresponds to the
highest localization to the lung. Most significantly, the predicted
behavior of σs versus NC binding in Fig. 3A agrees remarkably
well with in vivo results in Fig. 3B.
Comparison with AFM Experiments. To make a direct comparison of
our computed PMF for NC binding with AFM force measure-
ments probing the interactions of anti-ICAM-1 functionalized
NC with EC surface, we computed the rupture-force distribution
(36) of the attached NC at different loading rates (see section S9
in SI Text). The computed force distribution in Fig. 4A, based on
our computed PMF profile for σs ¼ 74%, reveals a mean rupture
force of 215–230 pN with a standard deviation of 40 pN at a
loading rates of 100–200 nN∕s.
The AFM experiments probing the interactions of the AFM tip
functionalized with antibody-bearing NCs were carried out. A
typical trace showing a single rupture event is shown in Fig. 4B;
triplet events were also observed in some cases (see Fig. S9A).
The complete distribution of experimental NC rupture forces
(see inset) shows a mean rupture force of 316 pN with a standard
deviation of 48 pN over 89 experiments. For comparison, AFM
experiments for ICAM-1 immobilized surface with AFM tip
directly functionalized with antibody (i.e., without NC) shows
a rupture force of 291 pN and a standard deviation of 32 pN over
174 experiments (Fig. S9B). The model results in panel A
compare favorably with experimentally determined rupture-force
measurements in the inset of panel B (see section S9 of SI Text
for a sensitivity analysis). As an additional check, we estimate the
reactive compliance to be γ ∼ 0.2 nm (see section S9 in SI Text),
which closely agrees with results from single-molecule experi-
ments (29, 30). Given that the rupture-force distribution is
governed mainly by k rather than by ΔG0 (see section S9 of
SI Text), the agreement of model predictions with AFMmeasure-
ments establishes a mechanical consistency of the model, which is
independent of the thermodynamic consistency achieved from
the close agreement of the computed binding affinity with that
measured in binding experiments. We also note that the predicted
multivalency of 3 evident from the PMF in Fig. 2 (for σs ¼ 74%)
is consistent with some (5–10%) of the AFM force traces which
record multiple rupture events (Fig. S9A).
Discussion
We present a general protocol to calculate the absolute binding
affinity for specific binding of NC to functionalized surfaces
mediated through receptor–ligand interactions. Our results for
the binding affinities of 100 nm antibody-coated NCs at large
surface coverage (σs ≥ 45%) to ICAM-1 expressing EC surface
shows several hundredfold enhancement in binding compared
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with that of isolated antibody to ICAM-1. This prediction agrees
remarkably well with experimental measurements of the NC
affinity to EC in cell culture (18), as depicted in Fig. S1. Our
results on the computed effect of surface coverage of antibodies
σs on NC binding suggests a linear effect of σs on Ka for 0 < σs <
45% and for ∼45% < σs ≤ 100%; in these regimes, the average
multivalency is not altered, and the linear effect arises from
contributions of translational and rotational entropy losses upon
NC binding (see red and green dotted lines in Fig. 3A). At the
threshold of antibody coverage σs ∼ 45% we predict an exponen-
tial effect of σs on Ka primarily due to a change in multivalency
associated with NC binding (Figs. S5 and S6). We note that
for σs > 45%, the increase in NC binding affinity with increasing
σs is only modest, while for σs⪅45%, the NC binding affinity
abruptly drops below that for free antibody with ICAM-1. Our
results imply a negligible effect of shear (S ≤ 6;000 s−1) when
σs ≥ 14% (see Fig. S6). Moreover, the glycocalyx while reducing
the fractional binding at a given σs, does not alter the dependence
of Ka on σs (see Fig. S7). We are therefore justified in comparing
the model results with in vivo data of NC binding and targeting
to mice endothelium. Most significantly, the model prediction of
σs versus NC binding agrees remarkably well with in vivo results
(see Fig. 3B), while simultaneously providing consistent agree-
ment with AFM force-rupture experiments (Fig. 4) as well as
in vitro equilibrium binding experiments (Fig. S1).
Our model is predictive for binding of spherical nanocarriers
to endothelial apical molecules and defining the critical threshold
of antibody density for effective anchoring as well as the asso-
ciated multivalent interactions. The practical significance is that,
exceeding the optimal surface density of antibody or other affinity
ligands on the surface of nanocarriers may predispose to immune
response to the protein. The model is designed to predict results
for targeting to a well appreciated target (ICAM-1) and can be
easily adapted to other endothelial molecules localized on the
apical luminal surface of endothelium at similar density to
ICAM-1 ∼105 copies per cell (angiotensin-converting enzyme,
VCAM-1, thrombomodulin, etc.). In the future, the model may
also be extended further to treat distinct endothelial epitopes
(such as molecules localized to the caveoli), filamentous carriers,
or intracellular uptake of carriers. Despite their absence in the
current model description, the remarkable agreement of the
computed results with three broad and independent classes of
experiments, namely, AFM rupture-force, in vitro binding
affinity, and in vivo endothelial targeting in mice, strongly imply
mechanical, thermodynamic, as well as physiological consistency.
On these bases, our model represents a promising tool for the
rational design of functionalized NCs in targeted drug delivery.
Materials and Methods
Preparation of NC. A solvent extraction emulsification procedure was used to
form PLGA NCs whose size (100 nm) and zeta-potential were determined on
a Brookhaven 90Plus zeta-potential and dynamic light scattering apparatus
(18). Anti-ICAM-1 nanocarriers were prepared by coating green fluorescent
polystyrene beads with antimurine ICAM-1 (18). Radiolabeled NCs were
prepared containing a mix of anti-ICAM-1 and 125I-IgG at 95∶5 molar ratio.
After separation of the free anti-ICAM-1 by centrifugation, the amount of
125I tracer coated onto the nanocarriers was determined in a gamma counter.
This procedure was employed to synthesize as well as characterize a range of
surface coverages of antibodies on NC (5% < σs ≤ 100%). The saturating anti-
body surface coverage on the NC surface was estimated to be 220 antibody
molecules per NC (or 7,000 antibody per μm2) (18, 34), which we assumed as
100% coverage. The diameter of the anti-ICAM-1 coated NCs was determined
by dynamic light scattering to be 92 6 nm.
In Vivo Targeting to Vascular Endothelium in Mice. Anesthetized C57BL/6
female mice (16–24 g, Harlan) were injected intravenously via jugular vein
with NCs coated with murine anti-ICAM-1 (YN1 clone, Biolegend) or control
rat IgG (Jackson Labs). The injected dose was ∼200 μl (or ∼10 mg∕kg) with a
tracer amount of antibody-coated 125I-labeled NC. Blood was collected from
the retro-orbital plexus at 30 min post-injection and organs (heart, kidneys,
liver, spleen, and lungs) were collected at 30 min post-injection. Radioactivity
and weight of the samples were determined to calculate NC targeting. These
studies were carried out in accordance with the Guide for the Care and Use of
Laboratory Animals as adopted and promulgated by the National Institutes
of Health.
AFM Experiments. Silicon nitride AFM cantilevers were functionalized with
maleimide-terminated flexible polyethylene glycol linkers (Novascan, Ames,
IA) having a nominal spring constant of 0.06–0.12 N∕m. These were incu-
bated with antibody-coated 1 μm diameter polystyrene beads in phos-
phate-buffered saline (PBS) (18, 34) for 10 min, then washed three times
to remove the excess. Recombinant human ICAM-1 (rhICAM; R&D Systems,
Minneapolis) at a concentration of 25 μg∕mL in PBS was adsorbed onto clean
glass coverslips for 15 min, then washed three times to remove the excess.
An atomic force microscope (Molecular Imaging 5500, Tempe, AZ) was
used in force spectroscopy mode to obtain force-distance cycles for functio-
nalized cantilever-functionalized coverslip interactions at fixed velocities of
1.6 μm∕s (corresponding to a force loading rate of 96–192 nN∕s). Experi-
ments were conducted in PBS at 20 °C. The negative control experiments
(performed by blocking available ICAM-1 sites by incubating with excess free
anti-ICAM-1 antibody) yielded no significant binding interaction between
the cantilever and the sample surface.
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